Nine years of qualification
Audited Supplier
In This Store
Changchun BCHT Biotechnology Co was established in March 2004 by the investment of Changchun High-technology Industry Development Property (Group)(Stock code: 000661.SZ). BCHT is a listed and high-tech enterprise engaged in R&D, production and marketing of biologics and drugs. In 2008, BCHT successfully launched its product Varicella Vaccine, Live in China. In the following years, BCHT continuously committed to improving the product and led in 2010 removal of gelatin from adjuvant and extension of the vaccine shelf-life up to 36 months which is the longest one in the world.
BCHT now covers 235,000 square meters for manufacturing sites and owns two R&D centers for vaccine and drug with the most equipped laboratories and pilot plants in the areas over 5000 square meters. For the last few years, the company’s R&D investment exceeds over 400 million RMB.
BCHT has been awarded as High-tech Enterprise, AAA Credit Enterprise, Quality Creditable Enterprise and assigned as Engineering Research Center for Modern Vaccines, Innovative Center for Science and Technology of Vaccine, Engineering Research Center for Vaccines at Changchun State Bio-Industry Base by Jilin province. BCHT has co-established National Engineering Laboratory for AIDS Vaccine with Jilin University.
Year of Establishment: 2004
Total Assets(USD):
Total Number of Staff: more than 1000
Main Competitive Advantages: Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages: For the company,many technical person, R&D person and management staff have rich experience in biopharmaceutical line for many years as well as overseas studying and working experince. Meanwhile, BCHT is Focus Support Enterprises by government for the inn
Patents and Copyrights: Varicella Vaccine, Live
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us：
Pharma Sources Insight JANUARY 2024
